Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
37 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03340506 | Dabrafenib and/or Trametinib Rollover Study | recruiting | Phase 4 | 100 | Novartis PharmaceuticalsINDUSTRY | 14 | Sep 23, 2026 | clinicaltrials |
| NCT07218341 | A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | recruiting | Phase 4 | 150 | Eli Lilly and CompanyINDUSTRY | 17 | Sep 22, 2026 | clinicaltrials |
| active not recruiting |
| Phase 4 |
| 654 |
| BayerINDUSTRY |
| 19 |
| Jul 6, 2026 |
| clinicaltrials |
| NCT04877522 | Asciminib Roll-over Study | recruiting | Phase 4 | 347 | Novartis PharmaceuticalsINDUSTRY | 29 | Jul 6, 2026 | clinicaltrials |
| NCT06440629 | Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)(RA-DRUM) | active not recruiting | Phase 4 | 387 | Diakonhjemmet HospitalOTHER | 6 | Jul 1, 2026 | clinicaltrials |
| NCT05803941 | Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer | recruiting | Phase 4 | 700 | Novartis PharmaceuticalsINDUSTRY | 11 | Jun 4, 2026 | clinicaltrials |
| NCT06717919 | HOPE Against Cancer Recurrence in HCC(HOPE4Cancer) | recruiting | Phase 4 | 220 | Philipp DutkowskiOTHER | 17 | Dec 16, 2025 | clinicaltrials |
| NCT00942968 | Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer | completed | Phase 4 | 338 | PfizerINDUSTRY | 5 | Apr 18, 2024 | clinicaltrials |
| NCT04593459 | Probiotic Intervention in PCOS(ProPCO-RCT) | completed | Phase 4 | 112 | Medical University of GrazOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT01735955 | Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study | completed | Phase 4 | 57 | Novartis PharmaceuticalsINDUSTRY | 16 | Feb 8, 2024 | clinicaltrials |
| NCT05900258 | Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face(SunDamage) | completed | Phase 4 | 22 | Medical University of GrazOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT00777127 | Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses(LEIDA) | completed | Phase 4 | 258 | MEDA Pharma GmbH & Co. KGINDUSTRY | 3 | Feb 7, 2022 | clinicaltrials |
| NCT01453179 | Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)(LEIDA 2) | completed | Phase 4 | 221 | MEDA Pharma GmbH & Co. KGINDUSTRY | 2 | Feb 7, 2022 | clinicaltrials |
| NCT04842422 | Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream | completed | Phase 4 | 48 | Medical University of GrazOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT01588184 | An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study | completed | Phase 4 | 95 | Hoffmann-La RocheINDUSTRY | 21 | Nov 5, 2020 | clinicaltrials |
| NCT02015650 | Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck | terminated | Phase 4 | 4 | Medical University InnsbruckOTHER | 1 | May 18, 2020 | clinicaltrials |
| NCT03988114 | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer(proMONARCH) | withdrawn | Phase 4 | 0 | Eli Lilly and CompanyINDUSTRY | 9 | Sep 6, 2019 | clinicaltrials |
| NCT01721915 | Vitamin D Treatment, Pharmacogenetics and Glucose Metabolism | completed | Phase 4 | 330 | Medical University of GrazOTHER | 1 | Mar 20, 2018 | clinicaltrials |
| NCT01538901 | Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients(AKtransplant) | terminated | Phase 4 | 10 | Medical University of ViennaOTHER | 1 | Sep 12, 2017 | clinicaltrials |
| NCT01639703 | Hepatic Xenetix-CT Perfusion | completed | Phase 4 | 96 | GuerbetINDUSTRY | 4 | Jul 13, 2017 | clinicaltrials |
| NCT01061177 | Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase('MACS1252) | completed | Phase 4 | 1,090 | Novartis PharmaceuticalsINDUSTRY | 26 | Feb 24, 2017 | clinicaltrials |
| NCT00949910 | An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 4 | 6,586 | Hoffmann-La RocheINDUSTRY | 51 | Oct 5, 2016 | clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT02562170 | Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study | completed | Phase 4 | 50 | Medical University of ViennaOTHER | 1 | Sep 29, 2015 | clinicaltrials |
| NCT01255644 | Antiviral Treatment of Chronic Lymphocytic Leukemia(VGCV-CLL) | completed | Phase 4 | 20 | Medical University of ViennaOTHER | 1 | Jul 21, 2015 | clinicaltrials |
| NCT01950871 | Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning(PHSTT-01) | terminated | Phase 4 | 80 | Advanced Medical Diagnostics s.a.INDUSTRY | 18 | Jan 5, 2015 | clinicaltrials |
| NCT00764621 | Health Economic Evaluation of Primovist-enhanced Liver MRI | completed | Phase 4 | 360 | BayerINDUSTRY | 9 | Nov 4, 2014 | clinicaltrials |
| NCT01758341 | Radiofrequency Ablation for Malignant Biliary Obstruction | completed | Phase 4 | 58 | Medical University of ViennaOTHER | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00420927 | Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis(OPTIMA) | completed | Phase 4 | 1,032 | AbbottINDUSTRY | 21 | Apr 18, 2012 | clinicaltrials |
| NCT00280514 | Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration | completed | Phase 4 | 20 | Medical University of ViennaOTHER | 1 | Aug 4, 2010 | clinicaltrials |
| NCT00090038 | Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 4 | 168 | BiogenINDUSTRY | 11 | Oct 20, 2009 | clinicaltrials |
| NCT00050999 | Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients | completed | Phase 4 | 195 | Eisai Inc.INDUSTRY | 10 | Mar 5, 2008 | clinicaltrials |
| NCT00051012 | Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients | completed | Phase 4 | 86 | Eisai Inc.INDUSTRY | 9 | Mar 5, 2008 | clinicaltrials |
| NCT00575523 | Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy(atropinePEI) | completed | Phase 4 | 31 | Medical University of ViennaOTHER | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00411541 | Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia | completed | Phase 4 | 2,600 | International BFM Study GroupNETWORK | 8 | Dec 14, 2006 | clinicaltrials |
Data updated 4 days agoSource updated unknownsource: clinicaltrials